Literature DB >> 1523284

Effects of chlorpromazine and lorazepam on explicit memory, repetition priming and cognitive skill learning in healthy volunteers.

J M Danion1, S Peretti, D Grangé, M Bilik, J L Imbs, L Singer.   

Abstract

To assess the influence of neuroleptics on explicit memory and two forms of implicit memory, repetition priming and cognitive skill learning, the effects of two low doses of chlorpromazine (12.5 and 25 mg orally) were contrasted to those of lorazepam (2.5 mg orally) and of a placebo using a free-recall task, a word-completion task and repeated testing on the Tower of Toronto puzzle, a version of the Tower of Hanoi puzzle. Seventy-two healthy volunteers took part in this double-blind study. Chlorpromazine spared free-recall and word-completion performance, but impaired the acquisition of a cognitive routine in the subjects who completed the first trials of the Tower of Toronto puzzle efficiently. Lorazepam induced an opposite pattern of memory disruption. These preliminary results suggest that chlorpromazine and lorazepam induced a double dissociation between priming and the acquisition of a cognitive routine. They provide evidence that the two forms of implicit memory rely upon distinct neurochemical systems, the latter, but not the former, being dependent upon dopaminergic systems.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1523284     DOI: 10.1007/bf02245122

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  31 in total

1.  Relationships between effects of a number of centrally acting drugs and personality.

Authors:  C KORNETSKY; O HUMPHRIES
Journal:  AMA Arch Neurol Psychiatry       Date:  1957-03

2.  Mechanisms of memory.

Authors:  L R Squire
Journal:  Science       Date:  1986-06-27       Impact factor: 47.728

3.  Different memory systems underlying acquisition of procedural and declarative knowledge.

Authors:  N J Cohen; H Eichenbaum; B S Deacedo; S Corkin
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

4.  Effects of scopolamine, trimipramine and diazepam on explicit memory and repetition priming in healthy volunteers.

Authors:  J M Danion; M A Zimmermann; D Willard-Schroeder; D Grangé; M Welsch; J L Imbs; L Singer
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Diazepam induces a dissociation between explicit and implicit memory.

Authors:  J M Danion; M A Zimmermann; D Willard-Schroeder; D Grangé; L Singer
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  The nature of lorazepam-induced amnesia.

Authors:  R G Lister; S E File
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  Diazepam and memory: evidence for spared memory function.

Authors:  J C Fang; J V Hinrichs; M M Ghoneim
Journal:  Pharmacol Biochem Behav       Date:  1987-11       Impact factor: 3.533

8.  Memory dysfunction and word priming in dementia and amnesia.

Authors:  A P Shimamura; D P Salmon; L R Squire; N Butters
Journal:  Behav Neurosci       Date:  1987-06       Impact factor: 1.912

9.  Preserved learning and retention of pattern-analyzing skill in amnesia: dissociation of knowing how and knowing that.

Authors:  N J Cohen; L R Squire
Journal:  Science       Date:  1980-10-10       Impact factor: 47.728

10.  A comparison of the psychological effects of acute and chronic administration of chlorpromazine and secobarbital (quinalbarbitone) in schizophrenic patients.

Authors:  C KORNETSKY; M PETTIT; R WYNNE; E V EVARTS
Journal:  J Ment Sci       Date:  1959-01
View more
  14 in total

Review 1.  Novel antipsychotics: issues and controversies. Typicality of atypical antipsychotics.

Authors:  E Stip
Journal:  J Psychiatry Neurosci       Date:  2000-03       Impact factor: 6.186

2.  Impairment of contrast sensitivity in long-term lorazepam users.

Authors:  Anne Giersch; Claude Speeg-Schatz; Monique Tondre; Sylvaine Gottenkiene
Journal:  Psychopharmacology (Berl)       Date:  2006-04-04       Impact factor: 4.530

3.  Effects of the amnesic drug lorazepam on complete and partial information retrieval and monitoring accuracy.

Authors:  M Izaute; E Bacon
Journal:  Psychopharmacology (Berl)       Date:  2006-08-17       Impact factor: 4.530

4.  Effects of lorazepam and diazepam on conscious and automatic memory processes.

Authors:  P Vidailhet; M Kazès; J M Danion; F Kauffmann-Muller; D Grangé
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

5.  Comparison of the spectrum of cognitive effects of alprazolam and adinazolam after single doses in healthy subjects.

Authors:  J C Fleishaker; P D Garzone; J H Chambers; K Sirocco; H Weingartner
Journal:  Psychopharmacology (Berl)       Date:  1995-07       Impact factor: 4.530

6.  Lorazepam and diazepam effects on memory acquisition in priming tasks.

Authors:  P Vidailhet; J M Danion; F Kauffmann-Muller; D Grangé; A Giersch; M van der Linden; J L Imbs
Journal:  Psychopharmacology (Berl)       Date:  1994-07       Impact factor: 4.530

7.  Differential effects of diazepam and lorazepam on repetition priming in healthy volunteers.

Authors:  F Sellal; J M Danion; F Kauffmann-Muller; D Grangé; J L Imbs; M Van der Linden; L Singer
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

8.  Cognitive skill learning in healthy older adults after 2 months of double-blind treatment with piribedil.

Authors:  Charles S Peretti; Fabien Gierski; Sophie Harrois
Journal:  Psychopharmacology (Berl)       Date:  2004-05-12       Impact factor: 4.530

9.  Psychopharmacological analysis of implicit and explicit memory: a study with lorazepam and the benzodiazepine antagonist flumazenil.

Authors:  K I Bishop; H V Curran
Journal:  Psychopharmacology (Berl)       Date:  1995-09       Impact factor: 4.530

10.  Procedural learning in schizophrenia after 6 months of double-blind treatment with olanzapine, risperidone, and haloperidol.

Authors:  Scot E Purdon; Neil Woodward; Stacy R Lindborg; Emmanuel Stip
Journal:  Psychopharmacology (Berl)       Date:  2003-06-24       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.